HPO |
HP:0410275 |
Lumbosacral hemangioma |
"A spinal cord hemangioma located in the lumbosacral spine region." [PMID:25449217] |
— |
HP:0001028 |
HPO |
HP:0410276 |
Supraumbilical raphe |
"An abnormality of the sternum that presents at birth as a ventral sternal non-union defect, due to an abnormality of the fusion of the layers of the skin. It presents as a scar-like line that extends upward from the umbilicus (belly button)." [https://www.chw.org/medical-care/birthmarks-and-vascular-anomalies-center/conditions/phace-syndrome/phace-syndrome-handbook/ventral-or-midline-abnormalities, PMID:24075092] |
— |
HP:0000766 |
HPO |
HP:0410277 |
Sternal pit |
"A sternal pit is a small indentation or dimple in the skin overlying the sternum of the chest. In some cases, the skin defect can be linear, extending several inches over the sternum." [https://www.chw.org/medical-care/birthmarks-and-vascular-anomalies-center/conditions/phace-syndrome/phace-syndrome-handbook/ventral-or-midline-abnormalities] |
— |
HP:0000766 |
HPO |
HP:0410278 |
Pituitary gland cyst |
"A fluid-filled sacs that develop on or near the pituitary gland." [https://www.chop.edu/conditions-diseases/pituitary-cysts] |
— |
HP:0010576 |
HPO |
HP:0410279 |
Atrophic pituitary gland |
"Partial or complete wasting (loss) of the pituitary gland." [DOI:10.1530/endoabs.44.EP82] |
— |
HP:0012506 |
HPO |
HP:0410280 |
Pediatric onset |
"Onset of disease manifestations before adulthood, defined here as before the age of 15 years, but excluding neonatal or congenital onset." [ORCID:0000-0002-0843-4271] |
— |
HP:0003674 |
HPO |
HP:0410281 |
Dyspepsia |
"A heterogeneous group of symptoms that are localized in the epigastric region. Typical dyspeptic symptoms include postprandial fullness, early satiation, epigastric pain and epigastric burning, but other upper gastrointestinal symptoms such as nausea, belching or abdominal bloating often occur." [PMID:23399526] |
— |
HP:0002027 |
HPO |
HP:0410282 |
Abnormal circulating amylase level |
"A deviation from the normal concentration of amylase in the blood, an enzyme which helps digest glycogen and starch. It is produced mainly in the pancreas and salivary glands." [NCIT:C16284] |
— |
HP:0010876 |
HPO |
HP:0410283 |
Positive blood acetaminophen test |
"Detection of acetaminophen in the blood." [] |
— |
HP:0410172 |
HPO |
HP:0410284 |
Positive norpropoxyphene blood test |
"Detection of norpropoxyphene in the blood, a major metabolite of the opioid analgesic drug dextropropoxyphene." [PubChem:18804] |
— |
HP:0410172 |
HPO |
HP:0410285 |
Positive meconium methadone test |
"Detection of methadone or its metabolite 2-ethylidene-1,5-dimethyl-3,3- diphenylpyrrolidine (EDDP) in meconium." [] |
— |
HP:0500098 |
HPO |
HP:0410286 |
Positive blood molindone test |
"Detection of molindone in the blood, an antipyschotic used for treatment of schizophrenia." [PubChem:23897] |
— |
HP:0410172 |
HPO |
HP:0410287 |
Intrathoracic hemangioma |
"A hemangioma, a benign tumor of the vascular endothelial cells, that is located in the intrathoracic or chest region." [] |
— |
HP:0001028 |
HPO |
HP:0410288 |
Hyperamylasemia |
"Increased level of amylase in the blood, an enzyme which helps digest glycogen and starch. It is produced mainly in the pancreas and salivary glands." [] |
— |
HP:0410282 |
HPO |
HP:0410289 |
Hypoamylasemia |
"Decreased level of amylase in the blood, an enzyme which helps digest glycogen and starch. It is produced mainly in the pancreas and salivary glands." [] |
— |
HP:0410282 |
HPO |
HP:0410290 |
Positive urine norpropoxyphene test |
"Detection of norpropoxyphene in urine." [] |
— |
HP:0031840 |
HPO |
HP:0410291 |
Negativism |
"Opposing or not responding to instructions or external stimuli." [PMID:28754582, PMID:30262571] |
— |
HP:0000708 |
HPO |
HP:0410292 |
Abnormal isohemagglutinin level |
"An abnormal level of isohemagglutinin in the blood. An isohemagglutinin refers to the naturally occurring antibodies in the ABO blood group system (i.e., anti-A in a group B person, anti-B in a group A person, and anti-A, anti-B, and anti-A,B in a group O person)." [] |
— |
HP:0012475 |
HPO |
HP:0410293 |
Absent isohemagglutinin level |
"Absent or undetectable level of isohemagglutinin. An isohemagglutinin refers to the naturally occurring antibodies in the ABO blood group system (i.e., anti-A in a group B person, anti-B in a group A person, and anti-A, anti-B, and anti-A,B in a group O person)." [PMID:25309532] |
— |
HP:0410292 |
HPO |
HP:0410294 |
Decreased specific antibody response to protein vaccine |
"A reduced ability to synthesize postvaccination antibodies against proteins in vaccines, as measured by antibody titer determination following vaccination." [PMID:26018535] |
— |
HP:0032140 |
HPO |
HP:0410295 |
Complete or near-complete absence of specific antibody response to tetanus vaccine |
"The inability to synthesize postvaccination antibodies against a tetanus antigen, as measured by antibody titer determination following vaccination." [] |
— |
HP:0410294 |
HPO |
HP:0410296 |
Complete or near-complete absence of specific antibody response to hepatitis B vaccine |
"The inability to synthesize postvaccination antibodies against a hepatisis B antigen, as measured by antibody titer determination following vaccination." [] |
— |
HP:0410294 |
HPO |
HP:0410297 |
Partial absence of specific antibody response to tetanus vaccine |
"A reduced ability to synthesize postvaccination antibodies against a tetanus antigen, as measured by antibody titer determination following vaccination." [] |
— |
HP:0410294 |
HPO |
HP:0410298 |
Partial absence of specific antibody response to hepatitis B vaccine |
"A reduced ability to synthesize postvaccination antibodies against a hepatitis B antigen, as measured by antibody titer determination following vaccination." [] |
— |
HP:0410294 |
HPO |
HP:0410299 |
Decreased specific antibody response to polysaccharide vaccine |
"A reduced ability to synthesize postvaccination antibodies against polysaccharides in vaccines, as measured by antibody titer determination following vaccination." [PMID:26018535] |
— |
HP:0032140 |